Figure 5
From: Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in gastric cancer
Construction of metabolic subtype specific prognostic model. (A,B) Patients were divided into high-risk and low-risk subgroup based best cutoff, Kaplan–Meier analysis demonstrated that patients with higher metabolic subtype-associated signature score exhibited worse overall survival in TCGA-STAD, ROC curves showing the predictive efficiency of the model on the 1-, 3-, and 5-years survival rate. (C–E) the prognostic difference was validated in 3 independent cohorts.
